Comparative Pharmacology
Head-to-head clinical analysis: M V I ADULT PHARMACY BULK PACKAGE versus M V I 12 ADULT.
Peer-Reviewed Evidence
Head-to-head clinical analysis: M V I ADULT PHARMACY BULK PACKAGE versus M V I 12 ADULT.
M.V.I. ADULT (PHARMACY BULK PACKAGE) vs M.V.I.-12 ADULT
Head-to-head clinical comparison of therapeutic indices and safety profiles.
M.V.I. Adult is a multivitamin formulation providing essential vitamins that serve as cofactors in various enzymatic reactions and metabolic pathways. Vitamin A is essential for vision and cell differentiation; B vitamins (B1, B2, B3, B5, B6, B7, B9, B12) act as coenzymes in energy metabolism, red blood cell production, and nerve function; Vitamin C is an antioxidant and cofactor for collagen synthesis; Vitamin D regulates calcium homeostasis; Vitamin E is an antioxidant; and Vitamin K is required for hepatic synthesis of clotting factors.
M.V.I.-12 Adult is a multivitamin combination that supplies essential vitamins (A, D, E, C, B1, B2, B3, B5, B6, B12, folic acid, biotin) to maintain normal metabolic functions, act as cofactors in enzymatic reactions, and support cellular respiration, antioxidant defense, and erythropoiesis.
FDA-approved: Prevention and treatment of vitamin deficiencies in adults requiring parenteral nutrition.Off-label: Correction of vitamin deficiencies in patients unable to tolerate oral intake; perioperative vitamin supplementation.
FDA-approved for intravenous administration to prevent or treat vitamin deficiencies in patients requiring parenteral nutritionOff-label: adjunct in severe malnutrition, alcoholism, malabsorption syndromes, and during hemodialysis
10 mL intravenously once daily, added to 500 mL of compatible infusion fluid and administered over 8-24 hours.
10 mL (one vial) added to 500 mL of IV fluid, infused over 8-24 hours once daily.
None Documented
None Documented
Variable; thiamine (B1) ~9-18 min; riboflavin (B2) ~66-84 min; pyridoxine (B6) ~15-20 days; ascorbic acid (C) ~16-20 days (in deficiency states) or ~10-14 days (normal); retinol (A) ~2-3 days; ergocalciferol (D2) ~19-48 hours; alpha-tocopherol (E) ~40-60 hours; phytonadione (K1) ~1-2 hours.
Variable by component: e.g., thiamine 9-18 days (tissue stores), vitamin C 10-20 days (depletion), vitamin A 50-100 days (liver stores). Clinical context: half-lives reflect slow depletion; daily dosing maintains plasma levels.
Vitamins are metabolized mainly in the liver via conjugation or transformation; water-soluble vitamins are excreted renally; fat-soluble vitamins (A, D, E, K) are stored in tissues and undergo enterohepatic circulation.
Vitamins are metabolized via various pathways: water-soluble vitamins (B-complex, C) are minimally metabolized and excreted renally; fat-soluble vitamins (A, D, E) are stored in tissues and hepatically metabolized; folic acid is reduced to tetrahydrofolate by dihydrofolate reductase.
Renal excretion of water-soluble vitamins (B-complex, C); bile/fecal elimination of fat-soluble vitamins (A, D, E, K). Approximate percentages: Vitamins B1, B2, B6, C: >90% renal; Vitamin A: 70% fecal, 30% renal metabolites; Vitamin D: 75% fecal, 25% renal; Vitamin E: >60% fecal; Vitamin K: 50% fecal, 50% renal.
Renal: water-soluble vitamins (B-complex, C) excreted in urine; fat-soluble vitamins (A, D, E, K) undergo biliary/fecal excretion. Specific percentages vary per component; e.g., vitamin C ~50% renal, thiamine ~30-70% renal as metabolites.
Thiamine: 90% bound to albumin; Riboflavin: 60% bound; Pyridoxine: 70-80% bound; Ascorbic acid: 25% bound; Retinol: 95% bound to retinol-binding protein; Calciferol: 85-90% bound to vitamin D-binding protein; Tocopherol: >90% bound to lipoproteins; Phylloquinone: 99% bound to lipoproteins.
Vitamin A: 100% (retinol-binding protein, albumin). Vitamin D: 85-90% (vitamin D-binding protein). Vitamin E: ~90% (lipoproteins). Vitamin K: ~99% (lipoproteins). B-complex: low binding (<5-30%). Vitamin C: 24% (albumin).
Water-soluble vitamins: 0.5-1.0 L/kg (total body water); fat-soluble vitamins: 5-10 L/kg (extensive tissue storage). Clinical meaning: High Vd for fat-soluble vitamins indicates large tissue reservoirs.
Variable: water-soluble vitamins confined to extracellular fluid (0.2-0.3 L/kg); fat-soluble vitamins larger due to adipose storage (e.g., vitamin D ~1.5 L/kg). Overall mean ~0.5 L/kg reflecting mixed distribution.
IV: 100% bioavailability. Not administered orally via this product.
Intravenous: 100%. Oral: not applicable; formulation is for IV use only. If extrapolated from oral vitamin absorption: variable (e.g., thiamine 5-10%, vitamin C 70-90%).
No dose adjustment required; M.V.I. Adult is a multivitamin formulation with no excipients requiring renal adjustment.
No dose adjustment required for renal impairment.
Caution in severe hepatic impairment (Child-Pugh Class C); monitor for vitamin accumulation, particularly fat-soluble vitamins. No specific dose adjustment established.
No specific adjustment; use caution in severe hepatic impairment.
Not recommended for use in children; alternative pediatric formulations are available.
Children 11 years and older: same as adult. Children under 11: 5 mL (one-half vial) daily.
No specific dose adjustment required; use standard adult dosing with monitoring for vitamin levels and renal function.
No specific adjustment; monitor for toxicity in elderly due to potential multivitamin accumulation.
None.
None
["Allergic reactions have been reported, especially with vitamin B1 (thiamine) and B12.","Aluminum toxicity: Contains aluminum, which may be toxic with prolonged use in renal impairment.","Reduce dosage in patients with liver disease or cholestasis.","Folic acid may mask vitamin B12 deficiency.","Ensure adequate hydration to avoid crystallization of vitamins in urine."]
["Allergic reactions including anaphylaxis may occur, especially in patients with hypersensitivity to any component","Do not exceed recommended dosage; vitamin A and D toxicity with prolonged high doses","Use with caution in patients with renal impairment or hypervitaminosis","May cause phlebitis or thrombophlebitis if infused rapidly"]
["Hypersensitivity to any component.","Pre-existing hypervitaminosis (e.g., vitamin A or D toxicity).","Patients with severe hepatic impairment or cholestasis (for vitamin K-containing product).","Concurrent use with certain drugs (e.g., methotrexate high dose due to folic acid antagonism)."]
["Known hypersensitivity to any component","Pre-existing hypervitaminosis A or D","Severe folate deficiency with untreated pernicious anemia (due to B12 content)","Wilson's disease (due to copper content in some formulations)"]
Data Pending Review
Data Pending Review
No specific food interactions, but as part of parenteral nutrition, oral diet should be coordinated with clinical nutrition team.
No specific food interactions for intravenous administration. However, if transitioning to oral nutrition, consider that this product contains fat-soluble vitamins (A, D, E, K) which require dietary fat for absorption. Avoid excessive intake of vitamin K-rich foods (e.g., leafy greens) if on warfarin.
M.V.I. Adult is a multivitamin formulation containing vitamins A, D, E, K, C, B1, B2, B3, B6, B9, B12, and B5. Therapeutic doses of individual vitamins generally have low teratogenic risk; however, excessive vitamin A (retinol) >10,000 IU/day is teratogenic (first trimester: CNS, cardiac, facial defects; second/third trimester: no increased risk with supplementation within RDA). Vitamin D excess may cause hypercalcemia and fetal anomalies. Folic acid (vitamin B9) is protective against neural tube defects. Overall, at recommended doses, the teratogenic risk profile is low, with specific risks only at supratherapeutic levels.
M.V.I.-12 ADULT is a multivitamin preparation. At recommended doses, no increased risk of congenital anomalies has been reported. However, high doses of vitamin A (retinol) can be teratogenic; this product contains retinol 3300 IU, which is below the teratogenic threshold (<10,000 IU/day). Use during pregnancy is generally considered safe when following recommended intakes.
Vitamins in M.V.I. Adult are excreted into breast milk; at recommended doses, they are considered compatible with breastfeeding. No adverse effects reported in nursing infants. The milk-to-plasma (M/P) ratio is not established for the combination product. Fat-soluble vitamins (A, D, E, K) achieve higher milk concentrations with maternal supplementation, but at RDA levels, infant exposure is within safe limits. Monitor infant for signs of toxicity only if maternal intake exceeds RDA.
The vitamins in M.V.I.-12 ADULT are normally present in breast milk and are considered compatible with breastfeeding at recommended doses. No specific M/P ratios are available for the combination product; individual vitamins have variable transfer. Caution with vitamin A doses exceeding 10,000 IU/day.
No adjustment in dosage is required during pregnancy when used at the recommended daily allowance for pregnant women. Pregnancy increases the demand for certain vitamins (e.g., folate, iron, vitamin D) but M.V.I. Adult provides standard amounts; specific deficiencies may require additional supplementation. No pharmacokinetic changes necessitate dose reduction.
Pharmacokinetic changes in pregnancy (e.g., increased plasma volume, renal clearance) may require increased intake of water-soluble vitamins. However, for M.V.I.-12 ADULT (a multivitamin for injection), standard dosing is typically appropriate. No specific dose adjustment recommendations are established; use as directed for supplementation to meet increased demands.
Category C
Category C
M.V.I. Adult is a multivitamin infusion indicated for parenteral nutrition. Monitor for hypersensitivity reactions, especially in patients with allergies to vitamin B1 or folic acid. Protect from light during administration due to photosensitivity of vitamins. Do not exceed recommended infusion rates to avoid phlebitis.
M.V.I.-12 ADULT is a multivitamin formulation for intravenous use, indicated when oral nutrition is not feasible. Contains vitamins A, D, E, K, B1, B2, B3, B5, B6, B12, C, and biotin. Use with caution in patients with renal impairment due to potential accumulation of vitamin A and D. Do not administer intramuscularly or as a bolus; infuse over at least 30 minutes. Requires protection from light during storage and administration. Vitamin K content may antagonize warfarin therapy.
This medication is a vitamin supplement given intravenously as part of your nutrition therapy.Inform your healthcare provider if you have a history of allergic reactions to any vitamins.Report any symptoms such as rash, itching, or difficulty breathing during the infusion.This product contains vitamin K; inform your doctor if you take blood thinners like warfarin.
This medication is given as an intravenous infusion, not a shot or by mouth.Inform your healthcare provider if you are on blood thinners like warfarin, as this product contains vitamin K.Report any signs of allergic reaction, such as rash, itching, or difficulty breathing.You may experience mild irritation at the infusion site; let your nurse know if it becomes painful or red.Do not take extra vitamin supplements unless directed by your doctor.